SRF Limited’s Q4FY23 Results

This is a brief update on fourth quarter results of SRF Limited. In Q4, Company was not only able to arrest the sequential decline in consolidated revenues witnessed over the last two quarters, but also reported a healthy q-o-q growth of 8.9%. Y-o-y growth was 6.4%. The growth can be attributed to a 19.6% q-o-q, and 33.7% y-o-y growth in revenues from chemicals business. Chemicals business now contributes 55.6% of the revenues, up from 44.3% in Q4FY22. 57% of the revenues of chemical business came from specialty segment and balance from fluorochemicals. In terms of earnings, chemicals business constituted almost 90% of the company’s overall EBIT in Q4.